Activation of the PI3K/Akt signaling pathway by IGF2BP2 (also known as Imp2, Insulin-like growth factor 2 mRNA-binding protein 2) promotes glioma progression, while its inhibition sensitizes glioma cells to temozolomide treatment (52). This evidence concerns the gene AKT1 and glioma.